secwatch.observer — SEC 8-K summary
======================================

Issuer:     BRAINSTORM CELL THERAPEUTICS INC. (BCLI)
CIK:        0001137883
Form:       8-K
Filed at:   2024-04-11T23:59:59+00:00
Accession:  0001104659-24-046001
Event type: other
Sentiment:  positive
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Brainstorm Cell regains Nasdaq minimum market value compliance
--------------------------------------------------------------

- Received Nasdaq notification on April 10, 2024 that it regained compliance with Listing Rule 5550(b)(2).
- Market value of listed securities was >= $35M for 11 consecutive business days (Mar 22 – Apr 9, 2024).
- Previous deficiency notice received November 6, 2023; matter now closed.
- Continued listing on Nasdaq Capital Market is no longer in jeopardy.
- Press release issued April 11, 2024 confirms compliance reinstatement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1137883/000110465924046001/0001104659-24-046001-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1137883/000110465924046001/tm2411567d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-046001

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer